Mirion Technologies, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Mirion Technologies reported a significant increase in Q2 2026 revenue driven by its Nuclear & Safety segment, though net income saw a slight decrease due to foreign currency fluctuations and increased operating expenses.
NYSE
Mirion Technologies, Inc. reported significant revenue and profit growth for Q3 2025, driven by strategic acquisitions and successful capital raises, positioning for continued expansion in medical and nuclear safety markets.
NYSE
10-Q: Mirion Technologies Reports Strong Q2 2025 Earnings Amid Strategic Debt Refinancing and Acquisition
Mirion Technologies, Inc. reported a significant turnaround in net income for the second quarter and first half of 2025, driven by revenue growth across both segments, reduced interest expenses, and a strategic debt refinancing, alongside the announcement of a key acquisition.
NYSE
Mirion Technologies saw revenue increase and net income turn positive in the first quarter of 2025, driven by growth in both its Medical and Nuclear & Safety segments.
NYSE
10-Q: Mirion Technologies Reports Third Quarter 2024 Results, Revenue Growth Offset by Restructuring Costs
Mirion Technologies saw revenue growth in both its Medical and Technologies segments in Q3 2024, but restructuring and other costs impacted overall profitability.
NYSE
Mirion Technologies saw revenue growth and a reduced net loss in the second quarter of 2024, driven by improvements in both its Medical and Technologies segments.
NYSE
Mirion Technologies saw a revenue increase in the first quarter of 2024, but the company still reported a net loss.